Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05384093

Outcomes of Treatment Using the ERMI Shoulder Flexionater ®

Study 1 - Adhesive Capsulitis Study - 110 patients The purpose of this study is to compare treatment of patients with symptoms of adhesive capsulitis, primary and secondary, between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.

Study 2 - Postoperative Shoulder Stiffness Study - 90 patients The purpose of this study is to compare treatment of patients with post-operative stiffness indicative of secondary adhesive capsulitis between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.

Study 3 - Stiffness after MUA Study - enroll all eligible patients (goal of at least 15) The purpose of this study is to compare treatment of patients who have undergone manipulation under anesthesia or lysis of adhesions between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Foundation for Orthopaedic Research and Education

Tampa, Florida, 33607, United States

Location status: Recruiting

Location contact

Deborah H Warren

CONTACT

[email protected]

813-978-9700 ext. 6766

About this study

Study 1 - Adhesive Capsulitis Study (AC)

Objective: The purpose of this study is to compare treatment efficacy of patients with symptoms of primary and secondary adhesive capsulitis between three groups: 1) Patients treated with Physical Therapy alone; 2) Patients treated with the ERMI Shoulder Flexionater® alone; 3) Patients treated with PT + Device in the treatment.

  • Prospective randomized control trial
  • Sample size - 110 patients
  • Study Groups:
  • Group I - Physical Therapy Only
  • Group II - Flexionater® only
  • Group III - Flexionater® and Physical Therapy
  • Length of study - 2-year follow-up from last enrolled patient

Study 2 - Postoperative Shoulder Stiffness Study (POS)

Objective: The purpose of this study is to compare treatment efficacy of patients with post-operative stiffness indicative of secondary adhesive capsulitis between three groups: I) Patients treated with Physical Therapy alone; II) Patients treated with the ERMI Shoulder Flexionater® alone; III) Patients treated with PT + Device in the treatment.

  • Prospective randomized control trial
  • Sample size - 90 enrolled patients
  • Study Groups:
  • Group I - Physical Therapy only
  • Group II - Flexionater® only
  • Group III - Flexionater® and Physical Therapy
  • Length of study - 2-year follow-up from last enrolled patient

Study 3 - Secondary Surgery Study (SAM)

Objective: The purpose of this study is to compare recovery of patients who have undergone a manipulation under anesthesia or a lysis of adhesions between three groups: 1) Patients treated with Physical Therapy alone; 2) Patients treated with the ERMI Shoulder Flexionater® alone; 3) Patients treated with PT + Device in the treatment.

  • Prospective randomized control trial
  • Sample size - 10 enrolled patients
  • Study Groups:
  • Group I Physical Therapy Only
  • Group II - - Flexionater® only
  • Group III - Flexionater® and Physical Therapy
  • Length of study - 2-year follow-up from last enrolled patient

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

For Study Group 1- Adhesive Capsulitis (AC)

Inclusion criteria

  • Exhibits symptoms of adhesive capsulitis i. Shoulder pain with limited motion for more than one month ii. AND ≤ 30 degrees external rotation with arm at side iii. AND ≤ 130 degrees forward flexion d. Cortisone shot for all patients

Exclusion criteria

  • a. No prior shoulder surgery b. Infection c. Rheumatoid arthritis d. Any structural or systemic disorder that could result in pain or ROM limitation i. Such as inflammatory joint disease, osteoarthritis evidenced on radiographs ii. full thickness rotator cuff tear as shown by ultrasound imaging iii. history of major trauma or surgery involving the shoulder

For Study Group 2 - Postoperative Shoulder Stiffness Study (POS)

Inclusion criteria

c. Is not recovering normally based on objective criteria set for screening process i. Step 1 - Follow patients -all post-op patients with indicated procedures (see # 7 for list.) ii. Step 2 - Screen Patients -does patient meets inclusion criteria at 6 weeks or 3 months of follow-up?

  • < 15 degrees external rotation with arm at side at 6 weeks post-op
  • OR < 90 degrees forward flexion at 3 months post-op iii. Step 3 - Enroll patients that meet inclusion criteria and assign group

Exclusion criteria

a. Revision surgery b. Infection c. Rheumatoid arthritis

  • Procedures included
  • Shoulder arthroscopic procedures (29827, 29828, 29823,29824, 29826)
  • ORIF Humerus fracture (23615)

For Study Group 3, Secondary Surgery Study (SAM)

Inclusion criteria

  • Underwent a manipulation under anesthesia or a lysis of adhesions procedure

Exclusion criteria

a. Infection b. Rheumatoid arthritis c. Any structural or systemic disorder that could result in pain or ROM limitation i. Such as inflammatory joint disease, osteoarthritis evidenced on radiographs ii. full thickness rotator cuff tear as shown by ultrasound imaging iii. history of major trauma or surgery involving the shoulder

  • Procedures included
  • Manipulation under anesthesia (23700)
  • Lysis of adhesions (29825)

Treatment and study plan

High Intensity Stretch Device

Device

High Intensity Stretch and Physical Therapy are used either together or alone to treat study arm.

Other names: Physical Therapy

Primary outcomes

  1. Shoulder Range of Motion Improvement

    Time frame: 3 months

    Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice

  2. Shoulder Range of Motion

    Time frame: 6 months

    Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice

  3. Shoulder Range of Motion

    Time frame: 12 months

    Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice

  4. Shoulder Range of Motion

    Time frame: 24 months

    Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice

  5. Shoulder Range of Motion

    Time frame: 6 weeks

    Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice

  6. Shoulder Range of Motion

    Time frame: baseline

    Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice

  7. VAS (Visual Analog Scale) Pain Score

    Time frame: 3 months

    Visual Analog Scale Pain Score 0 (no pain) - 10 (pain as bad as it can be)

  8. VAS Pain Score

    Time frame: 6 weeks

    Visual Analog Scale Pain Score: 0 (no pain) - 10 (pain as bad as it can be)

  9. VAS Pain Score

    Time frame: 6 months

    Visual Analog Scale Pain Score: 0 (no pain) - 10 (pain as bad as it can be)

  10. VAS Pain Score

    Time frame: 12 months

    Visual Analog Scale Pain Score: 0 (no pain) - 10 (pain as bad as it can be)

  11. VAS Pain Score

    Time frame: 24 months

    Visual Analog Scale Pain Score: 0 (no pain) - 10 (pain as bad as it can be)

  12. VAS Pain Score

    Time frame: baseline

    Visual Analog Scale Pain Score: 0 (no pain) - 10 (pain as bad as it can be)

  13. ASES Score

    Time frame: baseline

    American Shoulder and Elbow Society Score (10 activities of daily living are calculated)

  14. ASES Score

    Time frame: 3 month

    American Shoulder and Elbow Society Score (10 activities of daily living are calculated)

  15. ASES Score

    Time frame: 6 weeks

    American Shoulder and Elbow Society Score (10 activities of daily living are calculated)

  16. ASES Score

    Time frame: 6 months

    American Shoulder and Elbow Society Score (10 activities of daily living are calculated)

  17. ASES Score

    Time frame: 12 months

    American Shoulder and Elbow Society Score (10 activities of daily living are calculated)

  18. ASES Score

    Time frame: 24 months

    American Shoulder and Elbow Society Score (10 activities of daily living are calculated)

Secondary outcomes

  1. SST

    Time frame: Baseline

    Simple Shoulder Test

  2. SST

    Time frame: 3 month

    Simple Shoulder Test

  3. SST

    Time frame: 6 weeks

    Simple Shoulder Test

  4. SST

    Time frame: 6 months

    Simple Shoulder Test

  5. SST

    Time frame: 12 months

    Simple Shoulder Test

  6. SST

    Time frame: 24 months

    Simple Shoulder Test

  7. Device Compliance Questionnaire (if applicable)

    Time frame: 6 weeks

    compliance with Device usage

  8. Device Compliance Questionnaire (if applicable)

    Time frame: 3 months

    compliance with Device usage

  9. Device Compliance Questionnaire (if applicable)

    Time frame: 6 months

    compliance with Device usage

Study contacts

Contact information is provided by the study sponsor or research team.

Deborah H Warren, RN

CONTACT

[email protected]

8139789700 ext. 6766

Viki Sochor

CONTACT

[email protected]

813-978-9700 ext. 6832

Sponsors and collaborators

Lead sponsor

Foundation for Orthopaedic Research and Education

Other

Collaborators

  • Ermi LLC

Registry information

Official study title

Outcomes of Treatment Using the ERMI Shoulder Flexionater®

Important dates

Study start
2019
Primary completion
2025
Study completion
2026
First posted
May 20, 2022
Registry last updated
Aug 7, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.